Drug Development and Industrial Pharmacy (DDIP)

Drug Development and Industrial Pharmacy is a subscription-based journal publishing novel, original, peer-reviewed research and review manuscripts related to pharmaceutical science research, specifically in the fields of nanomedicines, formulation, development and delivery technologies, biopharmaceuticals, new material development, processing technology advancement, and preclinical, clinical and regulatory evaluation of formulation and delivery technologies. Research papers must be hypothesis driven and emphasize innovative breakthrough topics. Timely critical review papers within the journal scope are also welcomed, alongside data notes, methods, and registered reports. The priority topics for the journal include: i. Nanomedicines ii. New Material Development iii. Advanced Formulation, Development and Delivery Technologies iv. Innovative Processing and Analytical Technologies v. Preclinical and Clinical Evaluation of Formulation Technologies vi. Regulatory Aspects

Drug Development and Industrial Pharmacy (DDIP) is :-

• International, Peer-Reviewed, Open Access, Refereed, nanomedicines, formulation, development and delivery technologies, biopharmaceuticals, new material development, processing technology advancement , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0363-9045, E-ISSN: 1520-5762, Established: 1974, Impact Factor: 2.4
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE